Montgomery Village, MD, United States of America

Karl A Werbovetz

This inventor holds 1 USPTO granted patent. Top assignee: Utah State University. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl A Werbovetz. Retrieved from https://idiyas.com/inventor/karl-a-werbovetz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karl A Werbovetz

Introduction

Karl A Werbovetz is an accomplished inventor based in Montgomery Village, MD (US). He has made significant contributions to the field of medical science, particularly in the area of controlling protozoan infections. His innovative approach has the potential to improve therapeutic treatments for vulnerable populations.

Latest Patents

Werbovetz holds a patent for a method of controlling protozoan infections using syringomycin-family lipodepsipeptides. This method specifically targets infections caused by protozoans, utilizing syringomycins, such as syringomycin E, to effectively control or prevent these infections. The patent emphasizes therapeutic treatment for mammals, including humans, who are exposed to protozoans. Additionally, it serves as a prophylactic treatment for immunocompromised individuals at high risk of contracting such infections.

Career Highlights

Karl A Werbovetz is affiliated with Utah State University, where he continues to engage in research and development in his field. His work has garnered attention for its innovative approach to addressing health challenges posed by protozoan infections.

Collaborations

Some of his notable coworkers include Jon Y Takemoto and John R Forney, who have collaborated with him on various research initiatives.

Conclusion

Karl A Werbovetz's contributions to the field of medical science through his innovative patent demonstrate his commitment to improving health outcomes for individuals at risk of protozoan infections. His work continues to inspire advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…